Rapid Micro Biosystems (RPID) welcomes Dr. Dafni Bika to the Company’s Board of Directors. Dr. Bika currently serves as Senior Vice President and Global Head of Pharmaceutical Technology and Development at AstraZeneca (AZN), where she leads a global team of scientists and engineers in advancing synthetic molecules into approved medicines.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RPID: